Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry.
JAMA Cardiol
; 2020 Nov 13.
Article
em En
| MEDLINE
| ID: mdl-33185662
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Observational_studies
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article